unknown
Stage
About
Broadwing Bio develops antibody therapies targeting genetically validated ophthalmology diseases such as Geographic Atrophy and Glaucoma to preserve vision and treat major causes of adult vision loss.
Explore Broadwing Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.